GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence

Journal of Clinical Epidemiology

Volumn 87, Issue , 2017, Pages 14-22

  Guyatt, Gordon H ^a   Ebrahim, Shanil ^a,b   Alonso Coello, Pablo ^a,c   Johnston, Bradley C ^a,b,d,e   Mathioudakis, Alexander G ^c   Briel, Matthias ^a,f   Mustafa, Reem A ^a,g   Sun, Xin ^h   Walter, Stephen D ^a   Heels Ansdell, Diane ^a   Neumann, Ignacio ⁱ   Kahale, Lara A ^j   Iorio, Alfonso ^a   Meerpohl, Joerg ^k,l   Schünemann, Holger J ^a   Akl, Elie A ^a,j  

^a MCMASTER UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

^g UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^h SICHUAN UNIVERSITY   (China)

ⁱ PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^j AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^k UNIVERSITY OF FREIBURG   (Germany)

^l PARIS DESCARTES UNIVERSITY   (France)

more..

Author keywords

GRADE; Missing participant data; Risk of bias; Systematic reviews; Trials

Indexed keywords

ARTICLE; DATA ANALYSIS; INTENTION TO TREAT ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL BIAS; FOLLOW UP; HUMAN; LITERATURE; METHODOLOGY; PATIENT DROPOUT; PRACTICE GUIDELINE; STATISTICS AND NUMERICAL DATA;

BIAS (EPIDEMIOLOGY); HUMANS; LOST TO FOLLOW-UP; PATIENT DROPOUTS; RESEARCH DESIGN; REVIEW LITERATURE AS TOPIC; RISK ASSESSMENT;

EID: 85021808658     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2017.05.005     Document Type: Article

References (37)

1. Guyatt, G.H., Oxman, A.D., Vist, G., Kunz, R., Brozek, J., Alonso-Coello, P., et al. GRADE guidelines: 4. Rating the quality of evidence–study limitations (risk of bias). J Clin Epidemiol 64 (2011), 407–415.
2. Balshem, H., Helfand, M., Schunemann, H.J., Oxman, A.D., Kunz, R., Brozek, J., et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64 (2011), 401–406.
3. Higgins, J.P.T., Green S, S., (eds.) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org.
4. Akl, E.A., Johnston, B.C., Alonso-Coello, P., Neumann, I., Ebrahim, S., Briel, M., et al. Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers. PLoS One, 8, 2013, e57132.
5. Ebrahim, S., Akl, E.A., Mustafa, R.A., Sun, X., Walter, S.D., Heels-Ansdell, D., et al. Addressing continuous data for participants excluded from trial analysis: a guide for systematic reviewers. J Clin Epidemiol 66 (2013), 1014–1021.e1.
6. Ebrahim, S., Johnston, B.C., Akl, E.A., Mustafa, R.A., Sun, X., Walter, S.D., et al. Addressing continuous data measured with different instruments for participants excluded from trial analysis: a guide for systematic reviewers. J Clin Epidemiol 67 (2014), 560–570.
7. Akl, E.A., Kahale, L.A., Agoritsas, T., Brignardello-Petersen, R., Busse, J.W., Carrasco-Labra, A., et al. Handling trial participants with missing outcome data when conducting a meta-analysis: a systematic survey of proposed approaches. Syst Rev, 4, 2015, 98.
8. Akl, E.A., Carrasco-Labra, A., Brignardello-Petersen, R., Neumann, I., Johnston, B.C., Sun, X., et al. Reporting, handling and assessing the risk of bias associated with missing participant data in systematic reviews: a methodological survey. BMJ Open, 5(9), 2015, e009368.
9. Akl, E.A., Shawwa, K., Kahale, L.A., Agoritsas, T., Brignardello-Petersen, R., Busse, J.W., et al. Reporting missing participant data in randomised trials: systematic survey of the methodological literature and a proposed guide. BMJ Open, 5(12), 2015, e008431.
10. Akl, E.A., Kahale, L.A., Ebrahim, S., Alonso-Coello, P., Schünemann, H.J., Guyatt, G.H., Three challenges described for identifying participants with missing data in trials reports, and potential solutions suggested to systematic reviewers. J Clin Epidemiol 76 (2016), 147–154.
11. Abraha, I., Montedori, A., Modified intention to treat reporting in randomised controlled trials: systematic review. BMJ, 340, 2010, c2697.
12. Abraha, I., Cherubini, A., Cozzolino, F., De Florio, R., Luchetta, M.L., Rimland, J.M., et al. Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study. BMJ, 350, 2015, h2445.
13. Schulz, K.F., Assessing allocation concealment and blinding in randomised controlled trials: why bother?. Evid Based Nurs 4:1 (2001), 4–6.
14. Alshurafa, M., Briel, M., Akl, E.A.A., Haines, T., Moayyedi, P., Gentles, S.J., et al. Inconsistent definitions for intention-to-treat in relation to missing outcome data: systematic review of the methods literature. PLoS One, 7, 2012, e49163.
15. Higgins, J.P., White, I.R., Wood, A.M., Imputation methods for missing outcome data in meta-analysis of clinical trials. Clin Trials 5 (2008), 225–239.
16. Mavridis, D., White, I.R., Higgins, J.P., Cipriani, A., Salanti, G., Allowing for uncertainty due to missing continuous outcome data in pairwise and network meta-analysis. Stat Med 34 (2015), 721–741.
17. Akl, E.A., Briel, M., You, J.J., Sun, W., Johnston, B.C., Busse, J.W., et al. Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review. BMJ, 344, 2012, e2809.
18. White, I.R., Higgins, J.P., Wood, A.M., Allowing for uncertainty due to missing data in meta-analysis–part 1: two-stage methods. Stat Med 27 (2008), 711–727.
19. White, I.R., Welton, N.J., Wood, A.M., Ades, A.E., Higgins, J., Allowing for uncertainty due to missing data in meta-analysis–part 2: hierarchical models. Stat Med 27 (2008), 728–745.
20. Turner, N.L., Dias, S., Ades, A.E., Welton, N.J., A Bayesian framework to account for uncertainty due to missing binary outcome data in pairwise meta-analysis. Stat Med 34 (2015), 2062–2080.
21. Geng, E.H., Emenyonu, N., Bwana, M.B., Glidden, D.V., Martin, J.N., Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA 300 (2008), 506–507.
22. Akl, E.A., Kahale, L., Barba, M., Neumann, I., Labedi, N., Terrenato, I., et al. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer. Cochrane Database Syst Rev, 7, 2014, CD006650.
23. Akl, E.A., Kahale, L., Sperati, F., Neumann, I., Labedi, N., Terrenato, I., et al. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. Cochrane Database Syst Rev, 6, 2014, CD009447.
24. Akl, E.A., Kahale, L., Terrenato, I., Neumann, I., Yosuico, V.E., Barba, M., et al. Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation. Cochrane Database Syst Rev, 7, 2014, CD006466.
25. Akl, E.A., Kahale, L.A., Ballout, R.A., Barba, M., Yosuico, V.E., van Doormaal, F.F., et al. Parenteral anticoagulation in ambulatory patients with cancer. Cochrane Database Syst Rev, 12, 2014, CD006652.
26. Akl, E.A., Ramly, E.P., Kahale, L.A., Yosuico, V.E., Barba, M., Sperati, F., et al. Anticoagulation for people with cancer and central venous catheters. Cochrane Database Syst Rev, 10, 2014, CD006468.
27. Lytvyn, L., Quach, K., Banfield, L., Johnston, B.C., Mertz, D., Probiotics and synbiotics for the prevention of postoperative infections following abdominal surgery: a systematic review and meta-analysis of randomized controlled trials. J Hosp Infect 92:2 (2016), 130–139.
28. Johnston, B.C., Ma, S.S., Goldenberg, J.Z., Thorlund, K., Vandvik, P.O., Loeb, M., et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med 157 (2012), 878–888.
29. Spencer, F.A., Sekercioglu, N., Prasad, M., Lopes, L.C., Guyatt, G.H., Culprit vessel versus immediate complete revascularization in patients with ST-segment myocardial infarction-a systematic review. Am Heart J 170 (2015), 1133–1139.
30. Spencer, F.A., Lopes, L.C., Kennedy, S.A., Guyatt, G.H., Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale. BMJ Open, 4(3), 2014, e004282.
31. Spencer, F.A., Prasad, M., Vandvik, P.O., Chetan, D., Zhou, Q., Guyatt, G.H., Longer- versus shorter-duration dual-antiplatelet therapy after drug-eluting stent placement: a systematic review and meta-analysis. Ann Intern Med 163 (2015), 118–126.
32. How to read clinical journals: V: to distinguish useful from useless or even harmful therapy. Can Med Assoc J 124:9 (1981), 1156–1162.
33. Johnston, B.C., Thorlund, K., Schunemann, H.J., Xie, F., Murad, M.H., Montori, V.M., et al. Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units. Health Qual Life Outcomes, 8, 2010, 116.
34. Guyatt, G.H., Thorlund, K., Oxman, A.D., Walter, S.D., Patrick, D., Furukawa, T.A., et al. GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes. J Clin Epidemiol 66 (2013), 173–183.
35. Guyatt, G.H., Feeny, D.H., Patrick, D.L., Measuring health-related quality of life. Ann Intern Med 118 (1993), 622–629.
36. Thorlund, K., Walter, S.D., Johnston, B.C., Furukawa, T.A., Guyatt, G.H., Pooling health-related quality of life outcomes in meta-analysis-a tutorial and review of methods for enhancing interpretability. Res Synth Methods 2 (2011), 188–203.
37. Akl, E.A., Kahale, L.A., Agarwal, A., Al-Matari, N., Ebrahim, S., Alexander, P.E., et al. Impact of missing participant data for dichotomous outcomes on pooled effect estimates in systematic reviews: a protocol for a methodological study. Syst Rev, 3, 2014, 137.